Doxorubicin Hydrochloride
Product Images NDC 43598-541

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 43598-541). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20mgcarton (20mgcarton)

20mgcarton (20mgcarton)
Packaging label for Doxorubicin Hydrochloride Liposome Injection 20 mg/10 mL (2 mg/mL) single-dose vial by Dr. Reddy's Laboratories Inc. The label highlights it is a liposomal formulation not substitutable for doxorubicin HCl, intended for intravenous infusion only, with storage instructions to refrigerate at 2°-8°C (36°-46°F) and not to freeze. The NDC code 43598-283-35 and a barcode are visible.*
FDA Label Image

20mgvial (20mgvial)

20mgvial (20mgvial)
Doxorubicin Hydrochloride Liposome Injection 20 mg/10 mL (2 mg/mL) vial label by Dr. Reddy's Laboratories Inc. The label states it is a liposomal formulation and cautions not to substitute for doxorubicin HCl. It is for intravenous infusion only, single-dose use, requiring dilution. Storage instructions include refrigeration (2-8°C).*
FDA Label Image

50mgcarton (50mgcarton)

50mgcarton (50mgcarton)
Packaging label for Doxorubicin Hydrochloride Liposome Injection, 50 mg/25 mL (2 mg/mL) single-dose vial by Dr. Reddy's Laboratories Inc. The label includes usage instructions, storage conditions (2°-8°C), and warnings that it is a liposomal formulation not substitutable for doxorubicin HCl. The product is for intravenous infusion only, with directions to discard unused portions and keep refrigerated. The label also shows barcodes, lot codes, and distributor information stating it is made in India.*
FDA Label Image

50mgvial (50mgvial)

50mgvial (50mgvial)
Label of Doxorubicin Hydrochloride Liposome Injection, 50 mg/25 mL (2 mg/mL) single-dose vial by Dr. Reddy's Laboratories Inc. The label includes usage instructions, storage conditions, dosage form, and a warning that it is a liposomal formulation and should not be substituted for Doxorubicin HCl. It advises the vial must be diluted before use and retained in carton until use.*
FDA Label Image

Graph (Graph)

Graph (Graph)
A Kaplan-Meier survival curve comparing the percentage of subjects progression-free over time (in months) between two treatments: Doxorubicin Hydrochloride combined with Bortezomib and Bortezomib alone. The graph includes a legend indicating censored data points and a table showing the number of subjects at risk over time for each treatment group.*
FDA Label Image

Hspc (Hspc)

Hspc (Hspc)
Chemical structure diagram showing a complex organic molecule with ester, phosphate, and quaternary ammonium functional groups, associated with the Doxorubicin Hydrochloride active ingredient from Dr. Reddy's Laboratories Inc.*
FDA Label Image

Mpeg (Mpeg)

Mpeg (Mpeg)
Chemical structure diagram showing the molecular formula of Doxorubicin Hydrochloride, illustrating its chemical bonds and functional groups with clear depictions of carbon chains, oxygen, nitrogen, sodium, and phosphate components.*
FDA Label Image

Peglyated (Peglyated)

Peglyated (Peglyated)
An illustration diagram showing the structural components of Doxorubicin Hydrochloride liposomal formulation. It highlights the aqueous core with entrapped doxorubicin HCl, surrounded by a liposomal bilayer, and an outer MPEG-DSPE coating.*
FDA Label Image

Stru (Stru)

Stru (Stru)
Chemical structure diagram of doxorubicin hydrochloride, illustrating its molecular framework with specific functional groups and stereochemistry.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.